Skip to main content

How Monogram Health plans to use its new $160 million round of funding

Through evidence-based data analytics, Frist said it’s now possible to identify early-stage patients with kidney disease, much the way his previous company, Aspire Health, did in identifying patients that would need palliative care.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.